News18 » Videos » News18 Shorts

Gilead To Work With Indian Pharma Companies For Making COVID-19 Drug

May 06, 2020 07:10 PM IST iVideos iVideos

Gilead Sciences Inc said on Tuesday it was in discussions with chemical and drug manufacturers to produce its experimental COVID-19 drug Remdesivir for Europe, Asia and the developing world through at least 2022. Gilead also said on Tuesday it was negotiating long-term licenses with several generic drugmakers in India and Pakistan to produce Remdesivir for developing countries.